How Capital Allocation Decisions Get Made

Somewhere in every trading firm, a decision gets made about which strategies get capital, how much, and on what schedule. In a small shop this might be one person's judgment call; in any firm past a handful of strategies, it becomes a formal process — often literally a capital allocation committee — precisely because leaving it informal creates predictable problems. The person who built a strategy is the worst-positioned person to decide objectively how much capital it deserves, and the strategy that's had the best month is not necessarily the one that deserves the next dollar.

The committee's job is to compare candidates that are genuinely hard to compare on a like-for-like basis: a mean-reversion equity strategy with a three-year track record, a brand-new statistical arbitrage strategy that just cleared incubation, and an existing macro strategy asking for more capital after a strong quarter. Each has a different history length, a different risk profile, and a different reason for asking. A committee structure forces the comparison to happen against shared criteria — risk-adjusted return, correlation to the rest of the book, capacity, drawdown history, and confidence in the track record given how long it is — rather than against whoever argues most persuasively in the room.

A concrete example: a strategy manager requests a doubling of allocation after six months of live results that beat the backtest. The committee doesn't just look at the headline return; it checks how correlated the strategy has become with other sleeves already in the book (a great standalone Sharpe ratio is worth less if it moves in lockstep with three other strategies the firm already runs), whether six months is long enough to distinguish skill from luck at that Sharpe level, and whether the strategy's capacity supports twice the size without materially higher costs. The request might be approved in part, deferred pending a longer track record, or approved with a ramp schedule rather than a lump-sum increase.

Committees also handle the less glamorous flip side: reducing or pulling capital from strategies that are underperforming, decaying, or have become too correlated with the rest of the book. This is often the harder decision politically, since it affects a manager's compensation and standing directly, which is exactly why a standing committee with pre-agreed criteria — rather than an ad hoc conversation — is the mechanism firms lean on to make it stick.

What this means in practice

The specific membership and cadence vary — some firms have a weekly committee, others convene one only for material changes — but the underlying purpose is constant: put capital decisions through a process that is repeatable, documented, and insulated from the natural bias of whoever is asking for more money. New quants often assume a great backtest or a hot streak should be self-evidently persuasive; understanding that it goes through a committee, against explicit criteria and often a longer track record than the requester would like, is part of understanding how capital actually moves inside a real firm.